MedCity News September 27, 2024
Precision medicine relies on understanding how differences affect drug response. Researchers can develop more precise treatments that are effective for more patients when prioritizing diversity.
Accessible, worldwide biomanufacturing solutions are imperative for various reasons including promoting health worldwide, prioritizing equitable access to treatments, and strengthening the resilience of health systems and economies. When we think about vaccine and drug development on a global scale, it’s important to note that it’s not a one-size-fits-all approach. Genetic and regional differences mean that vaccines and drugs must be tailored to effectively meet the unique requirements of various populations. True equity in biomanufacturing can be achieved but is multi-faceted, with social and technical considerations.
Accessibility starts with understanding why genetic differences in humans...
Today's Sponsors
Today's Sponsor